Page last updated: 2024-08-26

zofenopril and Cardiovascular Diseases

zofenopril has been researched along with Cardiovascular Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Nucci, G; Dicay, M; MacNaughton, WK; Vaughan, D; Wallace, JL1
Borghi, C; Omboni, S1
Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Omboni, S; Vinereanu, D1
Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D; Omboni, S; Reggiardo, G1
Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D1
Ivleva, AIa1
Borghi, C; Cicero, AF1

Reviews

6 review(s) available for zofenopril and Cardiovascular Diseases

ArticleYear
Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic.
    Antioxidants & redox signaling, 2018, 06-01, Volume: 28, Issue:16

    Topics: Animals; Arthritis; Captopril; Cardiovascular Agents; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Hydrogen Sulfide; Naproxen

2018
Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update.
    Expert review of cardiovascular therapy, 2014, Volume: 12, Issue:9

    Topics: Animals; Antihypertensive Agents; Blood Pressure; C-Reactive Protein; Captopril; Cardiovascular Diseases; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Practice Guidelines as Topic; Risk Factors

2014
Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Control
    Journal of cardiovascular pharmacology, 2017, Volume: 69, Issue:1

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Treatment Outcome

2017
A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:9

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Heart; Humans; Hypertension; Myocardial Infarction

2004
[Efficacy of a new ACE inhibitor zofenopril (zocardis) in cardiovascular diseases].
    Terapevticheskii arkhiv, 2006, Volume: 78, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Humans; Treatment Outcome

2006
Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.
    Vascular health and risk management, 2006, Volume: 2, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Severity of Illness Index; Treatment Outcome

2006

Other Studies

1 other study(ies) available for zofenopril and Cardiovascular Diseases

ArticleYear
Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.
    Cardiovascular therapeutics, 2016, Volume: 34, Issue:2

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Diabetic Cardiomyopathies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Systole; Ventricular Dysfunction, Left

2016